JinkoSolar, the global leading PV and ESS supplier, recently announced today the signing of a major agreement with PM Green, a company active in the development and management of sustainable energy ...
The most talked about afterparty in Cannes celebrated the brand's inaugural fashion show welcoming an international cast of designers that debuted The House of Magnum® Collection ...
Strategic Initiative Strengthens Berlin as Europe's Hub of Digital Cardiology. BERLIN, May 19, 2026 /PRNewswire/ -- BIOTRONIK, die Charité – Universitätsmedizin Berlin, and th ...
Since January 2026, Bali Zoo has officially transitioned away from elephant riding, introducing Elephant Explorer, a guided immersive experience designed around animal welfare, education, and ...
AIMX Singapore 2026 Unites Three Flagship Platforms in a Landmark Convergence of Innovation, Technology and Industry. SINGAPORE, May 19, 2026 /PRNewswire/ -- Recognising AI as a h ...
The announcement builds on the successful execution of two utility-scale projects in India where First Solar's modules have been deployed on GameChange Solar's Genius Tracker™ s ...
The inaugural Asia edition of the global litigation finance conference series brings together leading litigation funders, law firms, general counsel, insurers, and institutional investors. SINGAPORE, ...
Coming in June, Kobo users can track their reading progress easier than ever with automatic StoryGraph sync. TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Rakuten Kobo, a global leade ...
The 28th Bakery China 2026 is set to open from May 20 to 23 at the National Exhibition and Convention Center (NECC) Shanghai. Co-organized by the China Association of Bakery & Confectionery Industry ...
Developed for 100kg-class agricultural and logistics UAVs, the platform integrates high-discharge performance, 6C fast charging, intelligent BMS control and lifecycle data access. LIVERMORE, Calif., ...
Strider identifies more than 6,000 joint publications and collaborations between researchers from 80 Australian organisations and Chinese government linked institutions since 2020. Collaborations ...
IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. Maximum dose reached with no dose-limiting toxicities observed. TLX101-Tx is also the subject of a pivotal trial, IPAX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results